Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/756
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sinclair, Rodney | - |
dc.contributor.author | Schwarer, Anthony | - |
dc.contributor.other | Tran, D. | - |
dc.contributor.other | Chow, C. W. | - |
dc.date | 2001-12 | - |
dc.date.accessioned | 2016-08-30T05:13:45Z | - |
dc.date.available | 2016-08-30T05:13:45Z | - |
dc.date.issued | 2000-05 | - |
dc.identifier.citation | Australas J Dermatol. 2000 May;41(2):106-8. | en_US |
dc.identifier.issn | 0365-3609 | en_US |
dc.identifier.issn | 1440-0960 | en_US |
dc.identifier.uri | http://hdl.handle.net/11434/756 | - |
dc.description.abstract | Alopecia can be a psychologically daunting prospect for people requiring cancer chemotherapy. Fortunately, most patients experience only temporary hair loss. We report the case of a 23-year-old woman with chronic myeloid leukaemia who developed permanent, near-total alopecia of her scalp, eyebrows, eyelashes, axillary and public hair following busulphan and cyclophosphamide chemotherapy which was used as conditioning prior to allogeneic bone marrow transplantation. The histology from a scalp biopsy revealed hair follicle destruction. Topical minoxidil failed to induce significant re-growth. | en_US |
dc.publisher | Wiley | en_US |
dc.subject | Adult | en_US |
dc.subject | Alopecia | en_US |
dc.subject | Chemically Induced | en_US |
dc.subject | Drug Therapy | en_US |
dc.subject | Antineoplastic Agents | en_US |
dc.subject | Alkylating | en_US |
dc.subject | Adverse Effects | en_US |
dc.subject | Antineoplastic Combined Chemotherapy Protocols | en_US |
dc.subject | Bone Marrow Purging | en_US |
dc.subject | Bone Marrow Transplantation | en_US |
dc.subject | Busulfan | en_US |
dc.subject | Cyclophosphamide | en_US |
dc.subject | Femail | en_US |
dc.subject | Hair Follicle | en_US |
dc.subject | Drug Effects | en_US |
dc.subject | Leukemia | en_US |
dc.subject | Minoxidil | en_US |
dc.subject | Therapeutic Use | en_US |
dc.subject | Chronic Myeloid Leukemia | en_US |
dc.subject | Hair Loss | en_US |
dc.subject | Department of Dermatology, Epworth Hospital, Richmond, Victoria, Australia | en_US |
dc.title | Permanent alopecia following chemotherapy and bone marrow transplantation. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1046/j.1440-0960.2000.00405.x | en_US |
dc.identifier.journaltitle | Australasian Journal of Dermatology | en_US |
dc.description.pubmeduri | http://www.ncbi.nlm.nih.gov/pubmed/10812705 | en_US |
dc.description.affiliates | Department of Dermatology, Alfred Hospital, Prahran, Australia. | en_US |
dc.type.studyortrial | Case Reports | en_US |
dc.type.contenttype | Text | en_US |
Appears in Collections: | Cancer Services Dermatology Head & Neck |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.